litlas
Log inCreate account

J A Ledbetter

Active 1977–1997

88
Papers
25,024
Citations
84
h-index
88
i10-index

Citations

Citations per year for J A Ledbetter1950: 1 citations1977: 1 citations1978: 2 citations1979: 3 citations1980: 2 citations1981: 16 citations1982: 20 citations1983: 24 citations1984: 26 citations1985: 41 citations1986: 40 citations1987: 82 citations1988: 96 citations1989: 106 citations1990: 160 citations1991: 219 citations1992: 322 citations1993: 446 citations1994: 668 citations1995: 535 citations1996: 539 citations1997: 427 citations1998: 449 citations1999: 402 citations2000: 349 citations2001: 233 citations2002: 217 citations2003: 186 citations2004: 112 citations2005: 146 citations2006: 82 citations2007: 114 citations2008: 77 citations2009: 99 citations2010: 67 citations2011: 60 citations2012: 61 citations2013: 61 citations2014: 46 citations2015: 68 citations2016: 56 citations2017: 71 citations2018: 65 citations2019: 191 citations2020: 155 citations2021: 144 citations2022: 122 citations2023: 74 citations2024: 148 citations2025: 56 citations2026: 1 citations1951–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,148 citing papers, 48.6% of this breakdownUnited Kingdom: 419 citing papers, 6.5% of this breakdownGermany: 366 citing papers, 5.7% of this breakdownCanada: 253 citing papers, 3.9% of this breakdownFrance: 249 citing papers, 3.8% of this breakdownJapan: 246 citing papers, 3.8% of this breakdownChina: 197 citing papers, 3% of this breakdownItaly: 171 citing papers, 2.6% of this breakdownNetherlands: 156 citing papers, 2.4% of this breakdownAustralia: 134 citing papers, 2.1% of this breakdownSwitzerland: 130 citing papers, 2% of this breakdownSweden: 88 citing papers, 1.4% of this breakdown
0%48.6%Other 14.2%

Institutions

Fields

  • Immunology and Microbiology46.3%
  • Medicine34.3%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences0.3%
  • Engineering0.2%
  • Other0.8%

Topics

  • T-cell and B-cell Immunology13.9%
  • Immune Cell Function and Interaction12.3%
  • Immunotherapy and Immune Responses9.1%
  • Monoclonal and Polyclonal Antibodies Research5%
  • Cancer Immunotherapy and Biomarkers3.3%
  • Immune Response and Inflammation3.3%
  • Other53.1%

Coauthors

All papers

Open in search
  1. CTLA-4 is a second receptor for the B cell activation antigen B7.

    Authors: Peter S. Linsley, William Brady, M Urnes, Laura S. Grosmaire, Nitin K. Damle, J A Ledbetter - The Journal of Experimental Medicine 1991 cited by 1,691

  2. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

    Authors: P S Linsley, JoAnne L. Greene, William Brady, Jürgen Bajorath, J A Ledbetter, Robert Peach - Immunity 1994 cited by 972

  3. The Role of the CD28 Receptor During T Cell Responses to Antigen

    Authors: P S Linsley, J A Ledbetter - Annual Review of Immunology 1993 cited by 1,313

  4. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

    Authors: Craig B. Thompson, Tullia Lindsten, J A Ledbetter, S L Kunkel, Howard A. Young, Stephen G. Emerson, Jeffrey M. Leiden, Carl H. June - National Academy of Sciences, Proceedings of the National Academy of Sciences 1989 cited by 659

  5. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

    Authors: Peter S. Linsley, Edward A. Clark, J A Ledbetter - National Academy of Sciences, Proceedings of the National Academy of Sciences 1990 cited by 748

  6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

    Authors: P S Linsley, JoAnne L. Greene, Peng Tan, J Bradshaw, J A Ledbetter, Claudio Anasetti, Nitin K. Damle - The Journal of Experimental Medicine 1992 cited by 583

  7. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

    Authors: P S Linsley, William Brady, Laura S. Grosmaire, Alejandro Aruffo, Nitin K. Damle, J A Ledbetter - The Journal of Experimental Medicine 1991 cited by 1,133

  8. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.

    Authors: Teresa M. Foy, Jon D. Laman, J A Ledbetter, Alejandro Aruffo, E Claassen, R J Noelle - The Journal of Experimental Medicine 1994 cited by 436

  9. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

    Authors: Lieping Chen, Stephanie Ashe, William Brady, Ingegerd Hellström, Karl Erik Hellström, J A Ledbetter, Patrick O. McGowan, Peter S. Linsley - Cell 1992 cited by 1,068

  10. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

    Authors: R J Noelle, Michael Roy, David M. Shepherd, Ivan Stamenkovic, J A Ledbetter, Alejandro Aruffo - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 cited by 810

  11. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes.

    Authors: Paul J. Martin, J A Ledbetter, Y Morishita, Carl H. June, P Beatty, J A Hansen - The Journal of Immunology 1986 cited by 195

  12. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

    Authors: Koen Gerritse, Jon D. Laman, Randolph J. Noelle, Alejandro Aruffo, J A Ledbetter, W J Boersma, E Claassen - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 493

  13. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

    Authors: Teresa M. Foy, David M. Shepherd, Fiona H. Durie, Alejandro Aruffo, J A Ledbetter, Randolph J. Noelle - The Journal of Experimental Medicine 1993 cited by 354

  14. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

    Authors: W. Conrad Liles, Peter A. Kiener, J A Ledbetter, Alejandro Aruffo, S J Klebanoff - The Journal of Experimental Medicine 1996 cited by 566

  15. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity.

    Authors: Diane Hollenbaugh, Laura S. Grosmaire, C.D. Kullas, N. Jan Chalupny, Sten Braesch‐Andersen, Randolph J. Noelle, Ivan Stamenkovic, J A Ledbetter, Alejandro Aruffo - The EMBO Journal 1992 cited by 513

  16. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

    Authors: Alejandro Aruffo, Mary Farrington, Diane Hollenbaugh, Xu Li, Athena Milatovich, Shigeaki Nonoyama, Jürgen Bajorath, Laura S. Grosmaire, Ronald E. Stenkamp, Michael Neubauer, Robert L. Roberts, R J Noelle, J A Ledbetter, Uta Francke, Hans D. Ochs - Cell 1993 cited by 826

  17. Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions.

    Authors: P Beatty, J A Ledbetter, Paul J. Martin, T. H. Price, J A Hansen - The Journal of Immunology 1983 cited by 298

  18. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells.

    Authors: Shigeaki Nonoyama, Diane Hollenbaugh, Alejandro Aruffo, J A Ledbetter, HD Ochs - The Journal of Experimental Medicine 1993 cited by 154

  19. An essential role for gp39, the ligand for CD40, in thymic selection.

    Authors: Teresa M. Foy, Dawne M. Page, Thomas J. Waldschmidt, Arjan H. Schoneveld, Jon D. Laman, Sally R. Masters, Lorraine T. Tygrett, J A Ledbetter, Alejandro Aruffo, E Claassen, Jun Xu, Richard A. Flavell, S Oehen, Stephen Μ. Hedrick, Randolph J. Noelle - The Journal of Experimental Medicine 1995 cited by 146

  20. CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.

    Authors: A Aruffo, Steven B. Kanner, Dennis C. Sgroi, J A Ledbetter, Ivan Stamenkovic - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 cited by 88

  21. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

    Authors: Patrick Tan, Claudio Anasetti, John A. Hansen, Jennifer Melrose, Mark W. Brunvand, J Bradshaw, J A Ledbetter, P S Linsley - The Journal of Experimental Medicine 1993 cited by 476

  22. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

    Authors: Edward A. Clark, J A Ledbetter - National Academy of Sciences, Proceedings of the National Academy of Sciences 1986 cited by 432

  23. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.

    Authors: C H June, Mary C. Fletcher, J A Ledbetter, Lawrence E. Samelson - The Journal of Immunology 1990 cited by 427

  24. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

    Authors: Madhuri Roy, Thomas J. Waldschmidt, Alejandro Aruffo, J A Ledbetter, Randolph J. Noelle - The Journal of Immunology 1993 cited by 371